600829.SS
600829.SS
CNE000000G05
HPGC RENMINTONGTAI PHARMACEUTIC
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 10.378.712.198 10.048.279.394
3.3%
Cost of Revenue 9.524.655.717 9.180.899.980
3.7%
Gross Profit 854.056.481 867.379.414
1.5%
563.605.406 543.285.845
3.7%
Operating Income 290.451.074 324.093.570
10.4%
Pretax Income 189.536.117 289.057.623
34.4%
Net Income Common Stockholders 133.839.930 213.272.260
37.2%
-- --
--
-- --
--
ende